Year All20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998 BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Sep 05, 2023 Read More BioCryst to Present at Upcoming Investor Conferences Aug 23, 2023 Read More BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Aug 04, 2023 Read More BioCryst Reports Second Quarter 2023 Financial Results and Provides Business Update Aug 03, 2023 Read More BioCryst to Report Second Quarter 2023 Financial Results on August 3 Jul 20, 2023 Read More BioCryst Selects Er-Kim Pharmaceuticals as Commercial Partner for ORLADEYO® (berotralstat) in Turkey Jul 19, 2023 Read More BioCryst to Participate in the 2023 US HAEA National Summit Jul 17, 2023 Read More BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Jul 06, 2023 Read More BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Jun 06, 2023 Read More BioCryst to Present at Upcoming Investor Conference Jun 01, 2023 Read More
BioCryst Reports Second Quarter 2023 Financial Results and Provides Business Update Aug 03, 2023 Read More
BioCryst Selects Er-Kim Pharmaceuticals as Commercial Partner for ORLADEYO® (berotralstat) in Turkey Jul 19, 2023 Read More